TrialClinical and translational science2022

Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first-in-class, first-in-human study.

Joo Young Na et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.